Retinal Vein Occlusion clinical trials at UC Davis

1 in progress, 0 open to eligible people

Showing trials for

  • Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

    Sorry, in progress, not accepting new patients

    This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.

    Sacramento, California

Our lead scientists for Retinal Vein Occlusion research studies include .

Last updated: